
1. malar j. 2014 jun 14;13:233. doi: 10.1186/1475-2875-13-233.

distinct patterns diversity, population structure evolution ama1
genes sympatric plasmodium falciparum plasmodium vivax populations of
papua new guinea area similarly high transmission.

arnott a, wapling j, mueller i, ramsland pa, siba pm, reeder jc, barry ae(1).

author information: 
(1)division infection immunity, walter eliza hall institute medical
research, melbourne, australia. barry@wehi.edu.au.

background: plasmodium falciparum plasmodium vivax co-exist most
malaria-endemic regions outside sub-saharan africa, malaria control strategies in
these areas must target species order succeed. population genetic
analyses predict effectiveness interventions including vaccines, by
providing insight patterns diversity evolution. aim study
was investigate population genetics leading malaria vaccine candidate
ama1 sympatric p. falciparum p. vivax populations papua new guinea
(png), area similarly high prevalence (pf = 22.3 38.8%, pv = 15.3 to
31.8%).
methods: total 72 pfama1 102 pvama1 sequences collected two
distinct areas, madang wosera, highly endemic png north coast.
results: despite greater number polymorphic sites ama1 genes p.
falciparum (madang = 52; wosera = 56) compared p. vivax (madang = 36,
wosera = 34), number ama1 haplotypes, haplotype diversity (hd) and
recombination (r) far lower p. falciparum (madang = 12, wosera = 20; hd
≤0.92, r ≤45.8) p. vivax (madang = 50, wosera = 38; hd = 0.99,
r = ≤70.9). balancing selection detected within domain ama1 p. 
vivax, domains iii p. falciparum.
conclusions: higher diversity genes encoding p. vivax ama1 p.
falciparum ama1 highly endemic area important implications for
development ama1-based vaccines png beyond. results also suggest 
a smaller effective population size p. falciparum compared p. vivax, a
finding warrants investigation. differing patterns selection on
the ama1 genes indicate critical antigenic sites may differ the
species, highlighting need independent investigations two
leading vaccine candidates.

doi: 10.1186/1475-2875-13-233 
pmcid: pmc4085730
pmid: 24930015  [indexed medline]

